Cheelcare Delivers First Curio Robotic Complex-Rehab Power Wheelchair to Paying Customers and Achieves Record Companion Sales

• On 9 Apr 2026 Cheelcare announced delivery of its first Curio robotic complex‑rehab power wheelchair to paying customers – the inaugural commercial shipment that initiates revenue generation for its flagship platform.
• The same release highlighted record Companion unit sales in March 2026, driven by expanding Medicare/Medicaid reimbursement and a growing pipeline of RFQs.
• A new 16,000 sq‑ft manufacturing facility is now fully operational, providing higher throughput and better quality control.
• Management emphasizes continued commercial expansion through demonstration units, conversion of the RFQ pipeline, and further production optimisation.

Aspect	Assessment
Revenue generation	First sales of Curio convert a previously non‑revenue R&D project into cash flow – a material positive shift.
Market perception	Demonstrates that the company can move from pilot to commercial scale, reducing execution risk perceived by investors.
Reimbursement environment	Recent Medicare/Medicaid support for Companion reduces price sensitivity and widens addressable market; Curio is positioned to benefit once FDA clearance proceeds.
Operational capacity	Completion of a dedicated plant removes a major bottleneck and signals ability to meet scaling demand.
Guidance vs. expectations	Prior guidance hinted at “commercial launch later in 2026.” The actual delivery ahead of year‑end exceeds that timeline, making the news materially positive relative to prior expectations.

Overall, the announcement materially improves the company’s near‑term revenue outlook and de‑riskes its flagship product rollout.

Cheelcare designs and manufactures assistive mobility solutions for individuals with limited lower‑extremity function. Its two core products are:

1. Companion Power‑Assist – an add‑on motor unit for manual wheelchairs, now reimbursable under U.S. Medicare/Medicaid (HCPCS E0986) and Canadian ADP programs.
2. Curio Robotic Complex‑Rehab Wheelchair – a fully powered wheelchair with integrated robotics for complex rehabilitation; the flagship platform that has just entered commercial production.

The company leverages a vertically integrated model: in‑house design, a 16,000 sq‑ft manufacturing hub (operational Oct 2025), and a global dealer network (>500 locations).